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Abstract
Background: More than 25 million adults in the United States have chronic pain. Chronic pain 
has been associated with suicidality, but previous studies primarily examined nonfatal suicidal 
behaviors rather than suicide deaths associated with chronic pain or the characteristics of such 
deaths.
Objective: To estimate the prevalence of chronic pain among suicide decedents in a large 
multistate sample and to characterize suicide decedents with and without chronic pain.
Design: Retrospective analysis of National Violent Death Reporting System (NVDRS) data. The 
NVDRS links death certificate, coroner or medical examiner, and law enforcement data collected 
by investigators, who often interview informants who knew the decedent to gather information on 
precipitating circumstances surrounding the suicide. Information is abstracted by using standard 
coding guidance developed by the Centers for Disease Control and Prevention.
Setting: 18 states participating in the NVDRS.
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Participants: Suicide decedents with and without chronic pain who died during 1 January 2003 
to 31 December 2014.
Measurements: Demographic characteristics, mechanism of death, toxicology results, 
precipitating circumstances (mental health, substance use, interpersonal problems, life stressors), 
and suicide planning and intent.
Results: Of 123 181 suicide decedents included in the study, 10 789 (8.8%) had evidence of 
chronic pain, and the percentage increased from 7.4% in 2003 to 10.2% in 2014. More than half 
(53.6%) of suicide decedents with chronic pain died of firearm-related injuries and 16.2% by 
opioid overdose.
Limitation: The results probably underrepresent the true percentage of suicide decedents who 
had chronic pain, given the nature of the data and how they were captured.
Conclusion: Chronic pain may be an important contributor to suicide. Access to quality, 
comprehensive pain care and adherence to clinical guidelines may help improve pain management 
and patient safety.
Primary Funding Source: None.
More than 25 million adults (11.2%) in the United States have some level of daily pain; 10.5 
million (4.6%) have considerable pain every day (1). Chronic pain costs $600 billion 
annually in medical care and lost productivity (2, 3), exceeding the costs associated with 
heart disease, cancer, or diabetes (3). Despite this societal toll, these statistics do not 
describe the effect of chronic pain on each person who has a diminished quality of life (2). 
The burden of chronic pain is difficult and imprecise to measure and often is undervalued in 
research, management, prevention, and policy development (2, 4).
Suicide has been increasing since 1999 (5) and is now the 10th leading cause of death in the 
United States (6). Recent findings suggest that chronic pain is associated with suicide (7, 8), 
and patients with chronic pain commonly have risk factors for suicide, including comorbid 
psychiatric conditions (such as depression and anxiety) (9, 10) and access to opioids used to 
treat chronic pain (7). However, previous studies primarily examined nonfatal suicidal 
behaviors rather than suicide deaths associated with chronic pain or the characteristics of 
such deaths (11–14). The purpose of our analysis was to better understand the burden of 
chronic pain among suicide decedents, thereby providing an indication of one effect that 
chronic pain may have on individuals and their quality of life.
METHODS
Data Sources
We analyzed data from 18 states participating in the National Violent Death Reporting 
System (NVDRS) for at least 1 year from 1 January 2003 to 31 December 2014. The 
NVDRS, described elsewhere (15), is an active, state-based surveillance system that links 
data on violent deaths (including suicides) from death certificates, coroner or medical 
examiner reports, and law enforcement reports into a single incident record (15). 
Information is abstracted by using standard coding guidance developed by the Centers for 
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Disease Control and Prevention (CDC). The NVDRS defines suicide as a death resulting 
from the intentional use of force against oneself, classified by the International Classification 
of Diseases, 10th Revision, cause-of-death codes X60 to X84, Y87.0, and U03 (16). 
Statewide NVDRS data have been collected in Maryland, Massachusetts, New Jersey, 
Oregon, South Carolina, and Virginia since 2003; Alaska, Colorado, Georgia, North 
Carolina, Oklahoma, Rhode Island, and Wisconsin since 2004; Kentucky, New Mexico, and 
Utah since 2005; Ohio since 2011; and Michigan since 2014.
More than 600 standard variables are coded in the NVDRS, including circumstances 
identified as directly contributing to the death (such as a physical health problem). Data on 
these precipitating circumstances often originate from investigators’ interviews with 
informants who knew the decedent. In addition, the NVDRS abstractors enter separate 
narratives based on reports from both coroners or medical examiners and law enforcement 
officers to summarize the events of the fatal incident and other pertinent information, 
including health conditions affecting the decedent.
Case Selection
We included decedents aged 10 years or older who died by suicide during 2003 to 2014 in 
this analysis. We identified cases with evidence of chronic pain by using keyword searches 
for 120 medical conditions and 9 pain types (allowing for common misspellings) in the 
coroner or medical examiner and law enforcement narratives. We selected these keywords 
on the basis of medical conditions and pain types associated with chronic pain from the 
American Chronic Pain Association (ACPA) (17).
We selected cases 3 ways (Figure 1). First, we selected cases that reported at least 1 medical 
condition primarily associated with chronic pain (such as “fibromyalgia”), pain classified by 
anatomical location (such as “back pain”) or organ system (such as “musculoskeletal pain”), 
or pain type consistent with chronic pain (such as “persistent pain”) (group 1). Second, we 
selected cases with medical conditions frequently associated with chronic pain, but not 
necessarily as the primary symptom (such as “sickle cell”), if the keyword “pain” (excluding 
“emotional” and “acute” pain) also was present and a contributing physical health problem 
was endorsed (group 2). Third, we selected cases with the keyword “pain” (excluding 
“emotional” and “acute” pain) and a contributing physical health problem (group 3) to 
maximize the capture of decedents with chronic pain. “Contributing physical health 
problem” is a standard NVDRS variable indicating that any physical health condition, such 
as terminal disease, debilitating condition, or chronic pain, was determined to be a 
contributing factor. This variable alone is too broad for defining cases of chronic pain but 
was used in groups 2 and 3 to increase specificity. We separately categorized pain by 
anatomical structure and medical condition by organ system by using a pain taxonomy 
prepared by the American Pain Society (18). Decedents may have had more than 1 medical 
condition in more than 1 pain category.
We reviewed the narratives of randomly selected decedents (n = 100 each from groups 1, 2, 
and 3) by using an iterative approach to further refine and validate our keyword search. 
Criteria for chronic pain cases were met if the decedent had any of the ACPA medical 
conditions or pain types described earlier, or if the narrative specifically indicated chronic 
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pain. Cases were excluded if the pain duration was documented as less than 3 months, the 
described pain referred exclusively to emotional pain, or the condition or pain type described 
applied to someone other than the decedent. Rater pairs conducted a final review of 216 
randomly selected cases (2.0%). Interrater agreement ranged from 92.6% to 96.2% (κ range, 
0.63 to 0.65); discrepancies were discussed and coded to consensus. In this analysis, 199 
decedents (92.1%) were true cases of chronic pain.
We also reviewed narratives of a random sample of 200 decedents with chronic pain who left 
suicide notes to determine whether the notes offered insights regarding the role of pain in 
precipitating suicide. Pain was determined to be a contributing factor if the suicide note 
included documentation that the decedent’s decision to die by suicide was because of pain. 
(For coding guidance used for the narrative review of suicide notes, see Appendix Table 1, 
available at Annals.org.)
Measures
We assessed the percentage of suicide decedents with chronic pain over time as well as the 
subset who died of prescription or illicit opioid overdose. We examined suicide decedents 
with and without chronic pain by demographic characteristics, mechanism of death, 
toxicology results, and precipitating circumstances.
Statistical Analysis
We examined the percentage of suicide decedents with evidence of chronic pain over time 
and used descriptive statistics to examine characteristics of suicide decedents with and 
without chronic pain across 12 data years (2003 to 2014). We used U.S. Census population 
data to calculate crude suicide rates per 100 000 persons by age group. Because of small 
sample sizes during 2003 to 2004, resulting in unstable rates, all reported rates represent 
annualized averages across 10 data years (2005 to 2014). We used SAS, version 9.3 (SAS 
Institute), for all analyses.
Role of the Funding Source
This study used data collected as part of routine injury surveillance and was not funded.
RESULTS
During 2003 to 2014, the NVDRS identified 123 181 suicide decedents aged 10 years or 
older, 10 789 (8.8%) of whom had evidence of chronic pain. The percentage of decedents 
with chronic pain increased from 7.4% in 2003 to 10.2% in 2014, but the percentage who 
died by opioid overdose remained low overall (<2.0%) (Figure 2).
Table 1 presents 7 pain categories and the 3 most common conditions within each category 
among suicide decedents with chronic pain. (For a full list of conditions and categories, see 
the Appendix and Appendix Tables 2 to 10, available at Annals.org.) The most common 
categories were spine pain (24.4%) and musculoskeletal pain (20.8%). The most common 
conditions were back pain (22.6%), cancer (12.5%), and arthritis (7.9%). More than half 
(54.4%) of decedents with chronic pain had 1 medical condition, 15.7% had 2 conditions, 
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and 5.7% had 3 or more conditions; the remaining decedents (24.2%) did not have a medical 
condition noted but had a qualifying keyword in the narrative.
Table 2 presents characteristics of suicide decedents. Those with chronic pain were older on 
average, and suicide rates increased with age and were highest among those aged 80 years or 
older. Nearly 1 in 3 suicide decedents (31.9%) with chronic pain were female, as were 21% 
of those without chronic pain. Of decedents both with and without chronic pain, most were 
non-Hispanic white (91.7% and 83.6%, respectively). More than a quarter of decedents 
(27.1%) with chronic pain had ever served in the military. The most common mechanism of 
death was firearm among decedents with chronic pain (53.6%) and those without it (51.4%), 
followed by opioid overdose (16.2%), other poisoning (13.3%), and hanging or suffocation 
(12.9%) among decedents with chronic pain, versus hanging or suffocation (25.6%), other 
poisoning (11.8%), and opioid overdose (3.9%) among those without chronic pain. Of 
decedents who had drug testing, 51.9% of those with chronic pain, but only 18.8% of those 
without it, had results positive for opioids; nearly half (47.2%) of those with and 31.7% of 
those without chronic pain had results positive for benzodiazepines.
More than half (51.7%) of suicide decedents with and 44.1% of those without chronic pain 
had a known mental health condition, with depression being the most common diagnosis in 
both groups. Most suicide decedents were not known to have problematic substance use. 
Approximately 20% of decedents with chronic pain and 31.2% of those without it had 
suspected alcohol use at the time of death. Abuse of substances other than alcohol was noted 
in 17.6% of decedents with and 14.8% of those without chronic pain.
A subset of decedents with chronic pain also were known to have life stressors related to job 
(10.5%) or financial problems (11.6%) or to interpersonal issues, such as intimate partner 
problems (16.9%) or an argument preceding the death (7.2%). However, 31.9% of decedents 
without chronic pain had intimate partner problems, and 12.0% had an argument preceding 
the death. Nearly one third of decedents with and without chronic pain had recent crises 
(27.7% and 29.3%, respectively).
Many decedents with and without chronic pain left suicide notes (41.4% and 32.8%, 
respectively), had a history of suicidal thoughts or plans (39.5% and 31.1%, respectively), 
had a history of suicide attempts (21.1% and 19.8%, respectively), or disclosed their intent 
to die by suicide (33.0% and 27.4%, respectively). In a random sample of 200 decedents 
with chronic pain who left suicide notes, approximately half (47.5%) of the narratives 
reported the contents of the notes; among these, 67.4% of decedents indicated that a pain 
condition or pain itself played a role in their decision to die by suicide. In the remaining 
notes, pain was not mentioned or the extent to which pain was a precipitating factor for the 
suicide was unclear.
DISCUSSION
We found that nearly 9% of suicide decedents in 18 states from 2003 to 2014 had 
documentation of chronic pain in their incident records and that the percentage of decedents 
with chronic pain increased during the study period. Our results highlight the importance of 
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pain in quality of life and premature death, and contribute to the growing body of evidence 
indicating that chronic pain might be an important risk factor for suicide (11–14).
We identified a wide variety of medical conditions and pain types among decedents, with 
back pain, cancer, and arthritis being the most common. Many chronic pain conditions have 
been associated with suicidality (9, 19–23), but the strength of association might differ by 
the specific pain condition (8). We did not stratify by medical condition or pain type when 
describing the characteristics of decedents, but future research might use the NVDRS to 
learn more about the pain conditions most strongly associated with suicide.
Establishing the causal role of pain in suicide was beyond our study’s scope. However, our 
results were consistent with the known epidemiology of chronic pain in terms of temporal 
trends, age, and sex (24). Other factors known to contribute to suicide risk, including 
interpersonal problems (25) and life stressors (26), were less frequent among decedents with 
chronic pain, which might indicate that chronic pain was the dominant stressor in this group. 
Also, although we cannot draw definitive conclusions regarding the proportion of suicides 
directly attributable to chronic pain, our narrative review of suicide notes suggests that the 
proportion was not trivial.
The proportion of suicide decedents with chronic pain increased during the study period. 
Chronic pain has increased in the general population by a similar magnitude (24), which 
may partially explain this finding. In general, suicide rates are higher among males and peak 
in middle age (5). However, suicide rates among decedents with chronic pain increased by 
age group and remained high among older persons. Health problems late in life are 
particularly associated with elevated suicide risk (27), and the prevalence of chronic pain, 
especially severe chronic pain, increases with age (24). Overall, we found considerably more 
suicides among males than females, regardless of chronic pain status, in agreement with the 
suicide literature (5). However, the difference was smaller among decedents with chronic 
pain, consistent with reports that chronic pain is more common in females (24).
Although opioid prescribing to treat chronic pain has increased in recent years (28), we 
found that the percentage of decedents with chronic pain who died by opioid overdose did 
not change over time. This finding suggests that increases in opioid availability are not 
associated with greater suicide risk from opioid overdose among patients with chronic pain. 
Additional research is needed to explore factors other than opioid availability that might be 
associated with suicide among persons living with chronic pain. Mental health disorders, 
particularly depression, were prevalent among decedents with chronic pain, consistent with 
previous findings (21,29). Chronic pain and depression have complex and bidirectional 
associations: Depression is a risk factor for chronic pain (30), and chronic pain, in turn, is a 
risk factor for depression (31, 32). Disentangling this complexity was not possible in our 
analysis. However, providers should be alert to and possibly screen for depression and 
suicidal behaviors among patients with chronic pain (29), especially older patients (27, 29). 
Indeed, a history of suicidal thoughts, plans, and attempts and disclosure of suicidal intent 
were more common among decedents with chronic pain than those without it, indicating that 
opportunities for intervention may have been available.
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A recent study suggests that among patients with chronic pain, a belief in a medical cure for 
their pain may act as a protective factor against suicidal ideation (33). This finding 
underscores the importance of access to quality, comprehensive pain care and adherence to 
best practices to improve both pain management and patient safety. The “CDC Guideline for 
Prescribing Opioids for Chronic Pain,” released in 2016, provides recommendations for 
prescribing opioid pain medication for patients aged 18 years or older in primary care 
settings (34). The recommendations, based on a systematic review of the existing scientific 
evidence, focus on the use of opioids in treating chronic pain outside active cancer 
treatment, palliative care, and end-of-life care (34). The guideline’s goal is to ensure that 
patients receive appropriate treatment for pain while considering the risks and benefits of 
treatment options (34). Integrated pain management and coordination of primary care, 
mental health care, and specialist services are essential for these patients. Other guidelines 
recommend behavioral health consultation for any patient with a history of suicide attempt 
or psychiatric disorder and advise against initiating opioid therapy during acute psychiatric 
instability or uncontrolled suicide risk (35).
In addition, the CDC’s suicide prevention technical package describes several evidence-
based prevention strategies relevant to patients with chronic pain: strengthening economic 
supports (such as disability benefit programs), strengthening access to and delivery of 
suicide care (such as mental health insurance coverage), and creating protective 
environments (such as reducing access to lethal means) (36). More than half of all suicide 
decedents, with and without chronic pain, died by firearm, whereas approximately 16% of 
those with chronic pain died by opioid overdose. Safe storage of firearms might reduce the 
risk for suicide in this population by separating persons at risk for suicide from easy access 
to lethal means (36). Safe storage practices may include education and counseling for 
storing firearms locked in a secure place, unloaded, and separated from ammunition for 
persons who may be at risk for suicide (36).
This analysis had limitations. First, data were obtained from 18 states and are not nationally 
representative, and the states included in the study varied over time. Second, our results 
probably underrepresent the true percentage of suicide decedents who had chronic pain, 
given the nature of the data and how they were captured. The reliability and validity of the 
medical diagnoses endorsed in the investigative reports also are unknown. Historically, 
patient reports and self-reported survey data have been the primary sources for pain 
estimates (1). Third, our case selection method led to relatively few false-positive results in 
our narrative review of selected cases, but a small percentage may have been misclassified, 
especially if pain was not a prominent issue reported by informants who knew the decedent. 
Fourth, we did not have information to assess pain characteristics, such as intensity and 
duration, or to determine medical treatment, and we could not distinguish prescription from 
illicit opioids. Finally, we could not assess other factors commonly associated with chronic 
pain that affect quality of life, such as disability, sleep disturbance, and in the case of 
terminal illness, the mental and physical effects of coping with end-of-life concerns.
Chronic pain is a public health problem that has been garnering increased attention since the 
2016 publication of “National Pain Strategy: A Comprehensive Population Health-Level 
Strategy for Pain” (4). Chronic pain also has implications for health care. Providers caring 
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for patients with chronic pain should be aware of the potential increased risk for suicide, and 
more effort may be needed to diagnose, manage, and treat chronic pain and comorbid mental 
health conditions. Continued surveillance and research are needed to better understand the 
burden of chronic pain in the United States.
APPENDIX:: DESCRIPTION OF THE APPENDIX TABLES
The purpose of Appendix Tables 2 through 10 is to provide a comprehensive overview of all 
the medical conditions and pain categories by anatomical location used in the keyword 
search for this study, as well as the frequencies of each condition identified. Appendix Table 
2 lists all the medical conditions and pain categories by anatomical location included in the 
keyword search, by decreasing order of frequency. Appendix Table 3 categorizes all the 
identified medical conditions by organ system and pain by anatomical location, and 
Appendix Tables 4 through 10 list the medical conditions by each organ system and pain by 
anatomical location, by decreasing order of frequency.
Appendix Table 1.
Suicide Note Narrative Review Coding Manual
Variable Valid Codes Definition Skip Pattern Examples
*
Reason 
present
y = yes Decedent included a 
reason for dying by 
suicide in the 
suicide note. The 
reason may or may 
not be related to 
chronic pain.
If code no, 
stop coding.
Code yes:
‘In a note to his wife, decedent says he 
has so much pain and discomfort from 
his cancer and decided to kill himself 
because he did not want his children to 
see him like this.’
‘Decedent left a note for her ex-
boyfriend saying that she was sorry and 
that she could no longer live without 
him.’
n = no
Code no:
‘Decedent left a note.’ (No other 
information about suicide note is in 
narrative.)
‘Decedent left suicide notes and a song 
consistent with suicidal intent.’ 
(However, content of notes does not 
include decedent’s reason for dying by 
suicide.)
‘Decedent left a note for his mother 
that said he could not go on.’
Direct 
attribution 
to pain
y = yes Decedent directly 
attributes decision 
to die by suicide to 
chronic pain.
If code yes or 
no, stop 
coding. If 
code 
unknown, 
proceed to #3.
Code yes:
‘In the notes, she described 
excruciating pain due to fibromyalgia 
and said her life was full of misery as a 
result.’
n = no
u = 
unknown
Code no:
‘Decedent left a note saying his wife 
recently died, and he could not live 
without her.’ (The reason for dying by 
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Variable Valid Codes Definition Skip Pattern Examples
*
suicide is given, but it is unrelated to 
chronic pain.)
Code unknown:
‘Decedent left several notes indicating 
that she could not take it anymore.’ (It 
is unclear based on note alone if “it” 
refers to pain or something else.)
Narrative 
informs 
attribution 
to pain
y = yes Remaining narrative 
provides enough 
information to 
suggest that the 
decedent’s reason 
for dying by suicide 
was chronic pain.
Code if 
answer 
unknown to 
#2.
Code yes:
‘Decedent left notes for his children 
where he said he was tired of hurting 
and that his body would not hold out 
any longer.’ (In the same narrative, it 
says that the decedent ‘often talked 
about his back pain.’)
n = no
u = 
unknown
Code no:
‘Decedent left several notes indicating 
that she couldn’t take it anymore.’ (In 
the same narrative, it says the decedent 
had recently lost her job and could no 
longer afford her diabetes medication. 
There is no mention of pain.)
Code unknown: same note content as “yes” 
example, but different narrative.
‘Decedent left notes for his children 
where he said he was tired of hurting 
and that his body would not hold out 
any longer.’ (In the same narrative, it 
states that according to the decedent’s 
brother, ‘he could not handle the pain 
of losing his girlfriend’ and that his 
heart failure was preventing him from 
doing the things he used to do. 
Decedent is also noted to have arthritis. 
Thus, it is unclear whether the 
“hurting” or “body would not hold out 
any longer” refers to the loss of his 
girlfriend, heart failure, or arthritis.)
*All examples consist of composite or fictional narratives.
Appendix Table 2.
Medical Conditions and Pain by Anatomical Location or Organ System in Suicide 
Decedents With Chronic Pain Aged ≥10 Years—NVDRS, 18 States, 2003–2014 (n = 10 
789)*
Medical Condition and Location of Pain Value, n (%)
Back pain 2441 (22.6)
Injury 1408 (13.1)
Cancer 1347 (12.5)
Arthritis 855 (7.9)
Migraine 559 (5.2)
Fibromyalgia 549 (5.1)
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Medical Condition and Location of Pain Value, n (%)
Diabetes (includes diabetic neuropathy) 531 (4.9)
Headache 500 (4.6)
Chronic obstructive pulmonary disease 282 (2.6)
Abdominal pain 254 (2.4)
Lower limb pain (e.g., leg, foot, or ankle pain) 203 (1.9)
Neck pain (includes “neck problem”) 186 (1.7)
Gout 166 (1.5)
Cerebrovascular accident (includes “stroke”) 150 (1.4)
Degenerative disc disease (includes “degenerative spine disease”) 135 (1.3)
Pain syndrome (nonspecific) 126 (1.2)
Neuropathy (includes “neuropathic pain,” excludes diabetic neuropathy) 122 (1.1)
Knee pain (includes “knee injury”) 105 (1.0)
Hip pain 95 (0.9)
Multiple sclerosis 95 (0.9)
Herpes zoster and postherpetic neuralgia (includes “shingles”) 78 (0.7)
Shoulder pain 74 (0.7)
Systemic lupus erythematosus 63 (0.6)
Spinal stenosis 60 (0.6)
Parkinson disease 57 (0.5)
Joint pain (includes “arthralgia”) 55 (0.5)
Sciatica 55 (0.5)
Inflammatory bowel disease (ulcerative colitis or Crohn disease) 54 (0.5)
Herniated disc 53 (0.5)
Pancreatitis 43 (0.4)
Scoliosis 42 (0.4)
HIV/AIDS 39 (0.4)
Nerve damage 31 (0.3)
Traumatic brain injury 28 (0.3)
Irritable bowel syndrome 23 (0.2)
Endometriosis 21 (0.2)
Nerve compression 21 (0.2)
Trigeminal neuralgia (includes “tic douloureux”) 21 (0.2)
Complex regional pain syndrome (includes “reflex sympathetic dystrophy,” “causalgia”) 20 (0.2)
Lyme disease 20 (0.2)
Neuralgia (excludes trigeminal neuralgia) 18 (0.2)
Radiculopathy (includes “radicular pain”) 17 (0.2)
Chronic fatigue syndrome 17 (0.2)
Muscle pain (includes “myofascial pain”) 16 (0.1)
Gallbladder pain 16 (0.1)
Polio 14 (0.1)
Pelvic pain 13 (0.1)
Dystonia 12 (0.1)
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Medical Condition and Location of Pain Value, n (%)
Temporomandibular joint disorder 12 (0.1)
Carpal tunnel syndrome 11 (0.1)
Spondylosis 10 (0.1)
Restless leg syndrome 9 (0.1)
Sjögren syndrome 8 (0.1)
Avascular necrosis (includes “osteonecrosis”) 7 (0.1)
Spinal cord injury 7 (0.1)
Hand pain 6 (0.1)
Ankylosing spondylitis 6 (0.1)
Pneumothorax (includes “collapsed lung”) 6 (0.1)
Sarcoidosis 6 (0.1)
Spina bifida 6 (0.1)
Interstitial cystitis 5 (<0.1)
Polymyalgia rheumatica 5 (<0.1)
Whiplash 5 (<0.1)
Amyotrophic lateral sclerosis 5 (<0.1)
Cerebral palsy 5 (<0.1)
Burning mouth syndrome –†
Chronic chest pain –†
Burn injury –†
Ehlers-Danlos syndrome –†
Myositis –†
Autoimmune disease (nonspecific) –†
Bursitis –†
Raynaud disease –†
Arachnoiditis –†
Dental pain –†
Musculoskeletal pain –†
Postlaminectomy syndrome –†
Connective tissue disease –†
Polymyositis –†
Sickle cell disease –†
Thoracic outlet syndrome –†
Phantom limb pain –†
Prostate pain –†
Vulvodynia –†
Cauda equina syndrome –†
Dermatomyositis –†
Encephalomyelitis –†
Primary lateral sclerosis –†
Adiposis dolorosa (e.g., Dercum disease) 0 (0)
Arthrofibrosis 0 (0)
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Medical Condition and Location of Pain Value, n (%)
Breakthrough pain 0 (0)
CADASIL 0 (0)
Cerebrospinal fluid leaks 0 (0)
Charcot-Marie-Tooth disease 0 (0)
Corneal neuropathic pain 0 (0)
Erythromelalgia 0 (0)
Failed back surgery syndrome 0 (0)
Hydrocephalus 0 (0)
Intercostal neuralgia 0 (0)
Loin pain hematuria syndrome 0 (0)
Lumbar Stenosis 0 (0)
Medullary sponge kidney 0 (0)
Meralgia paresthetica 0 (0)
Mitochondrial disorder 0 (0)
Nontraumatic joint disorder 0 (0)
Occipital neuralgia 0 (0)
Paget disease 0 (0)
Pinched nerve 0 (0)
Postherniorrhaphy pain syndrome 0 (0)
Postmastectomy pain syndrome 0 (0)
Postthoracotomy pain syndrome 0 (0)
Sacroiliac joint dysfunction 0 (0)
Soft tissue syndrome 0 (0)
Sphincter of Oddi dysfunction 0 (0)
Spinal cerebellum ataxia 0 (0)
Syringomyelia 0 (0)
Tarlov cysts 0 (0)
Torticollis 0 (0)
Transverse myelitis 0 (0)
Vascular pain 0 (0)
CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; NVDRS = 
National Violent Death Reporting System.
*
Decedents could have had >1 medical condition or pain by anatomical location or organ system.
†Value is not reported when number of deaths is <5.
Appendix Table 3.
Pain Categories by Organ System and Anatomical Structure in Suicide Decedents With 
Chronic Pain Aged ≥10 Years—NVDRS, 18 States, 2003–2014 (n = 10 789)*
Pain Category Value, n (%)
Spine pain 2637 (24.4)
Musculoskeletal pain 2245 (20.8)
Disease-associated pain conditions not classified elsewhere 1708 (15.8)
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Pain Category Value, n (%)
Orofacial and head pain 1073 (9.9)
Peripheral nervous system 873 (8.1)
Abdominal, pelvic, and urogenital pain 404 (3.7)
Central nervous system 352 (3.3)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition in >1 pain category. Medical condition was not identified in 2612 
decedents (24.2%).
Appendix Table 4.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Spine Pain Category—NVDRS, 18 
States, 2003–2014 (n = 2637)*
Spine Pain Condition Value, n (%)
Back pain 2441 (92.6)
Degenerative disc disease 135 (5.1)
Spinal stenosis 60 (2.3)
Herniated disc 53 (2.0)
Scoliosis 42 (1.6)
Radiculopathy 17 (0.6)
Spondylosis 10 (0.4)
Ankylosing spondylitis 6 (0.2)
Arachnoiditis –†
Postlaminectomy syndrome –†
Failed back surgery syndrome 0 (0)
Lumbar stenosis 0 (0)
Sacroiliac joint dysfunction 0 (0)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
Appendix Table 5.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Musculoskeletal Pain Category—
NVDRS, 18 States, 2003–2014 (n = 2245)*
Musculoskeletal Pain Condition Value, n (%)
Arthritis 855 (38.1)
Fibromyalgia 549 (24.5)
Lower limb pain 203 (9.0)
Neck pain 186 (8.3)
Gout 166 (7.4)
Pain syndrome (nonspecific) 126 (5.6)
Knee pain 105 (4.7)
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Musculoskeletal Pain Condition Value, n (%)
Hip pain 95 (4.2)
Shoulder pain 74 (3.3)
Joint pain 55 (2.5)
Chronic fatigue syndrome 17 (0.8)
Muscle pain 16 (0.7)
Restless leg syndrome 9 (0.4)
Avascular necrosis 7 (0.3)
Hand pain 6 (0.3)
Polymyalgia rheumatica 5 (0.2)
Whiplash 5 (0.2)
Burn injury –†
Myositis –†
Bursitis –†
Raynaud disease –†
Polymyositis –†
Musculoskeletal pain –†
Dermatomyositis –†
Adiposis dolorosa 0 (0)
Arthrofibrosis 0 (0)
Erythromelalgia 0 (0)
Nontraumatic joint disorder 0 (0)
Paget disease 0 (0)
Soft tissue syndrome 0 (0)
Torticollis 0 (0)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
Appendix Table 6.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Disease-Associated Pain Conditions 
Not Classified Elsewhere Category—NVDRS, 18 States, 2003–2014 (n = 1708)*
Disease-Associated Pain Condition Not Classified Elsewhere Value, n (%)
Cancer 1347 (78.9)
Chronic obstructive pulmonary disease 282 (16.5)
Systemic lupus erythematosus 63 (3.7)
Lyme disease 20 (1.2)
Polio 14 (0.8)
Dystonia 12 (0.7)
Sjögren syndrome 8 (0.5)
Pneumothorax 6 (0.4)
Sarcoidosis 6 (0.4)
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Disease-Associated Pain Condition Not Classified Elsewhere Value, n (%)
Chronic chest pain –†
Ehlers-Danlos syndrome –†
Autoimmune disease (nonspecific) –†
Connective tissue disease –†
Sickle cell disease –†
Mitochondrial disorder 0 (0)
Sphincter of Oddi dysfunction 0 (0)
Vascular pain 0 (0)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
Appendix Table 7.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Orofacial and Head Pain Category—
NVDRS, 18 States, 2003–2014 (n = 1703)*
Orofacial and Head Pain Condition Value, n (%)
Migraine 559 (52.1)
Headache 500 (46.6)
Temporomandibular joint disorder 12 (1.1)
Burning mouth syndrome –†
Dental pain –†
Corneal neuropathic pain 0 (0)
Hydrocephalus 0 (0)
Occipital neuralgia 0 (0)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
Appendix Table 8.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Peripheral Nervous System Category—
NVDRS, 18 States, 2003–2014 (n = 873)*
Peripheral Nervous System Condition Value, n (%)
Diabetes (includes diabetic neuropathy) 531 (60.8)
Neuropathy 122 (14.0)
Herpes zoster and postherpetic neuralgia 78 (8.9)
Sciatica 55 (6.3)
HIV/AIDS 39 (4.5)
Nerve damage 31 (3.6)
Nerve compression 21 (2.4)
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Peripheral Nervous System Condition Value, n (%)
Trigeminal neuralgia 21 (2.4)
Complex regional pain syndrome 20 (2.3)
Neuralgia 18 (2.1)
Carpal tunnel syndrome 11 (1.3)
Thoracic outlet syndrome –†
Phantom limb pain –†
Charcot-Marie-Tooth disease 0 (0)
Intercostal neuralgia 0 (0)
Meralgia paresthetica 0 (0)
Pinched nerve 0 (0)
Postherniorrhaphy pain syndrome 0 (0)
Postmastectomy pain syndrome 0 (0)
Postthoracotomy pain syndrome 0 (0)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
Appendix Table 9.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Abdominal, Pelvic, and Urogenital 
Pain Category—NVDRS, 18 States, 2003–2014 (n = 404)*
Abdominal, Pelvic, and Urogenital Pain Condition Value, n (%)
Abdominal pain 254 (62.9)
Inflammatory bowel disease 54 (13.4)
Pancreatitis 43 (10.6)
Irritable bowel syndrome 23 (5.7)
Endometriosis 21 (5.2)
Gallbladder 16 (4.0)
Pelvic pain 13 (3.2)
Interstitial cystitis 5 (1.2)
Prostate pain –†
Vulvodynia –†
Loin pain hematuria syndrome 0 (0.0)
Medullary sponge kidney 0 (0.0)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
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Appendix Table 10.
Medical Conditions by Organ System and Pain by Anatomical Location in Suicide 
Decedents With Chronic Pain Aged ≥10 Years in the Central Nervous System Category—
NVDRS, 18 States, 2003–2014 (n = 352)*
Central Nervous System Condition Value, n (%)
Cerebrovascular accident 150 (41.6)
Multiple sclerosis 95 (27.0)
Parkinson disease 57 (16.2)
Traumatic brain injury 28 (8.0)
Spinal cord injury 7 (2.0)
Spina bifida 6 (1.7)
Amyotrophic lateral sclerosis 5 (1.4)
Cerebral palsy 5 (1.4)
Cauda equina syndrome –†
Encephalomyelitis –†
Primary lateral sclerosis –†
CADASIL 0 (0)
Cerebrospinal fluid leaks 0 (0)
Spinal cerebellum ataxia 0 (0)
Syringomyelia 0 (0)
Tarlov cysts 0 (0)
Transverse myelitis 0 (0)
CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; NVDRS = 
National Violent Death Reporting System.
*
Decedents could have had >1 medical condition.
†Value is not reported when number of deaths is <5.
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Figure 1. 
Case selection process for suicide decedents with chronic pain.
NVDRS = National Violent Death Reporting System.
* Circumstance variable indicating that the decedent was having physical health problems 
(e.g., chronic pain, terminal disease, debilitating condition) that seem to have contributed to 
the death.
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Figure 2. 
Percentage of suicide decedents with chronic pain aged 10 years or older, by year, in 18 
states—NVDRS, 2003–2014.
The solid line indicates the percentage of suicide decedents with chronic pain (all 
mechanisms). The dashed line shows the percentage of suicide decedents with chronic pain 
who died by opioid overdose, among all suicides (n = 123 181) during 2003 to 2014. 
NVDRS = National Violent Death Reporting System.
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Table 1.
Pain Categories and the 3 Most Common Medical Conditions per Category in 18 States—NVDRS, 2003–2014 
(n = 10 789)*
Pain Categories and the 3 Most Common Medical Conditions per Category Value, n (%)
Spine pain 2637 (24.4)
 Back pain 2441 (22.6)
 Degenerative disc disease 135 (1.3)
 Spinal stenosis 60 (0.6)
Musculoskeletal pain 2245 (20.8)
 Arthritis 855 (7.9)
 Fibromyalgia 549 (5.1)
 Lower limb pain 203 (1.9)
Disease-associated pain conditions not classified elsewhere 1708 (15.8)
 Cancer 1347 (12.5)
 Chronic obstructive pulmonary disease 282 (2.6)
 Systemic lupus erythematosus 63 (0.6)
Orofacial and head pain 1073 (9.9)
 Migraine 559 (5.2)
 Headache 500 (4.6)
 Temporomandibular joint syndrome 12 (0.1)
Peripheral nervous system 873 (8.1)
 Diabetes (including diabetic neuropathy) 531 (4.9)
 Neuropathy 122 (1.1)
 Herpes zoster and postherpetic neuralgia 78 (0.7)
Abdominal, pelvic, and urogenital pain 404 (3.7)
 Abdominal pain 254 (2.4)
 Inflammatory bowel disease 54 (0.5)
 Pancreatitis 43 (0.4)
Central nervous system 352 (3.3)
 Cerebrovascular accident 150 (1.4)
 Multiple sclerosis 95 (0.9)
 Parkinson disease 57 (0.5)
NVDRS = National Violent Death Reporting System.
*
Decedents could have had >1 medical condition in >1 pain category.
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